Abstract | OBJECTIVE: METHODS: One hundred and twenty patients with acute ST-segment elevation myocardial infarction ( STEMI) admitted to our hospital between December 1, 2018 and December 31, 2019 were selected and randomly allocated to the experimental group (group A, n = 60) and the control group (group B, n = 60). In the experimental group, an infusion of nicorandil was given intravenously before the first balloon dilation or 1 minute before the stent placement, and with the completion of the infusion, nicorandil maintenance infusion was given. In the control group, only balloon dilation and stent placement were undertaken. RESULTS: The postoperative peak levels of myoglobin, creatine kinase isoform and hypersensitive troponin T were significantly lower in group A than in group B (p < 0.05). Moreover, the left ventricular ejection fraction (LVEF) on the 180th day post operation was substantially greater in group A than in group B (p < 0.01), and the area of myocardial infarction was significantly smaller in patients in group A than those in group B on the 180th day post operation (p < 0.01). In terms of the safety, there were no statistically significant differences in the incidence of slow flow/no reflow, malignant arrhythmias, and hypotension within 24 hours post operation between the two groups (p > 0.05), and no major adverse cardiovascular event ( MACE) occurred in either group during the postoperative follow-up period of 180 days (p > 0.05). CONCLUSION:
|
Authors | Zheng-Dong Wang, Hao Li, Ming Liu, Ping Li, Jian Chen, Xiang-Wen Liang, Xian-Zhang Zhu, Wang Liao |
Journal | Clinical hemorheology and microcirculation
(Clin Hemorheol Microcirc)
Vol. 77
Issue 4
Pg. 411-423
( 2021)
ISSN: 1875-8622 [Electronic] Netherlands |
PMID | 33386796
(Publication Type: Journal Article)
|
Chemical References |
- Antihypertensive Agents
- Nicorandil
|
Topics |
- Administration, Intravenous
(methods)
- Antihypertensive Agents
(pharmacology, therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Nicorandil
(pharmacology, therapeutic use)
- Percutaneous Coronary Intervention
(methods)
- Perioperative Period
- ST Elevation Myocardial Infarction
(drug therapy)
- Treatment Outcome
|